Jack Anders

Chief Financial Officer

Jack Anders (Chief Financial Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Revolution Medicines, Inc. (RVMD). The largest single filing was $3.3M of RVMD (19,700 sh across 3 lots, as filed), executed Jun 24.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 8 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$7.1M

shares × price, as filed

Last traded

Sep 16

Filed Sep 18

Median ADV $548.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $8.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 8 filings

Sector per market data · by filing · past 12 months

Most traded names

RVMD

Revolution Medicines, Inc. RVMD · 0 buys · 12 sells 12 filings

Recent filings

RVMDSALE Revolution Medicines, Inc. View filing → $796K
3,992 sh × $199.30
Exec Sep 16
Filed Sep 18 · 6:00 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $3.3M
19,700 sh across 3 lots
Exec Jun 24
Filed Jun 26 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $425K
2,722 sh × $156.12
Exec Jun 16
Filed Jun 18 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $274K
2,753 sh × $99.48
Exec Mar 17
Filed Mar 19 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $980K
10,000 sh × $98.00
Exec Jan 7
Filed Jan 9 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $239K
3,104 sh × $77.09
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $401K
5,418 sh × $74.00
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $640K
10,000 sh × $64.00
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET More filings →